278 related articles for article (PubMed ID: 15876871)
1. CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?
Lolli G; Johnson LN
Cell Cycle; 2005 Apr; 4(4):572-7. PubMed ID: 15876871
[TBL] [Abstract][Full Text] [Related]
2. MAT1 ('menage à trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK.
Devault A; Martinez AM; Fesquet D; Labbé JC; Morin N; Tassan JP; Nigg EA; Cavadore JC; Dorée M
EMBO J; 1995 Oct; 14(20):5027-36. PubMed ID: 7588631
[TBL] [Abstract][Full Text] [Related]
3. Is Cdk7/cyclin H/MAT1 the genuine cdk activating kinase in cycling Xenopus egg extracts?
Fesquet D; Morin N; Doree M; Devault A
Oncogene; 1997 Sep; 15(11):1303-7. PubMed ID: 9315098
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
Yankulov KY; Bentley DL
EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for CDK7 activation by MAT1 and Cyclin H.
Peissert S; Schlosser A; Kendel R; Kuper J; Kisker C
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26739-26748. PubMed ID: 33055219
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CAK kinase activity by p53.
Schneider E; Montenarh M; Wagner P
Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
[TBL] [Abstract][Full Text] [Related]
7. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
[TBL] [Abstract][Full Text] [Related]
8. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
[TBL] [Abstract][Full Text] [Related]
9. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors.
Inamoto S; Segil N; Pan ZQ; Kimura M; Roeder RG
J Biol Chem; 1997 Nov; 272(47):29852-8. PubMed ID: 9368058
[TBL] [Abstract][Full Text] [Related]
10. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.
Ali S; Heathcote DA; Kroll SH; Jogalekar AS; Scheiper B; Patel H; Brackow J; Siwicka A; Fuchter MJ; Periyasamy M; Tolhurst RS; Kanneganti SK; Snyder JP; Liotta DC; Aboagye EO; Barrett AG; Coombes RC
Cancer Res; 2009 Aug; 69(15):6208-15. PubMed ID: 19638587
[TBL] [Abstract][Full Text] [Related]
11. Xpd/Ercc2 regulates CAK activity and mitotic progression.
Chen J; Larochelle S; Li X; Suter B
Nature; 2003 Jul; 424(6945):228-32. PubMed ID: 12853965
[TBL] [Abstract][Full Text] [Related]
12. A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression.
Schachter MM; Merrick KA; Larochelle S; Hirschi A; Zhang C; Shokat KM; Rubin SM; Fisher RP
Mol Cell; 2013 Apr; 50(2):250-60. PubMed ID: 23622515
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity.
Wohlbold L; Larochelle S; Liao JC; Livshits G; Singer J; Shokat KM; Fisher RP
Cell Cycle; 2006 Mar; 5(5):546-54. PubMed ID: 16552187
[TBL] [Abstract][Full Text] [Related]
14. The cryoelectron microscopy structure of the human CDK-activating kinase.
Greber BJ; Perez-Bertoldi JM; Lim K; Iavarone AT; Toso DB; Nogales E
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22849-22857. PubMed ID: 32855301
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts.
Hamada K; Takuwa N; Zhou W; Kumada M; Takuwa Y
Biochim Biophys Acta; 1996 Jan; 1310(1):149-56. PubMed ID: 9244189
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.
Rossignol M; Kolb-Cheynel I; Egly JM
EMBO J; 1997 Apr; 16(7):1628-37. PubMed ID: 9130708
[TBL] [Abstract][Full Text] [Related]
17. The cdk-activating kinase (CAK): from yeast to mammals.
Kaldis P
Cell Mol Life Sci; 1999 Feb; 55(2):284-96. PubMed ID: 10188587
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CAK activities from human cells.
Kaldis P; Solomon MJ
Eur J Biochem; 2000 Jul; 267(13):4213-21. PubMed ID: 10866826
[TBL] [Abstract][Full Text] [Related]
19. CDK7 inhibitors as anticancer drugs.
Sava GP; Fan H; Coombes RC; Buluwela L; Ali S
Cancer Metastasis Rev; 2020 Sep; 39(3):805-823. PubMed ID: 32385714
[TBL] [Abstract][Full Text] [Related]
20. Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery.
Fisher RP
Transcription; 2019 Apr; 10(2):47-56. PubMed ID: 30488763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
